Dr. Harshad Vithalbhai Amin, MD

Dr. Amin practices at South Florida Oncology and Hematology Consultants in Plantation, Florida.

Dr. Amin's NPI, 1679807242, was assigned on September 29, 2009. Dr. Amin holds Florida license ME118635.

Dr. Amin's primary practice is South Florida Oncology and Hematology Consultants, at 260 SW 84th Ave, Plantation, FL 33324 in Broward County. The practice phone is (954) 749-6951.

Dr. Amin's primary practice is South Florida Oncology and Hematology Consultants in Plantation, Florida. Dr. Amin is also affiliated with HCA Florida Westside Hospital. The medical group on file is South Florida Oncology and Hematology Consultants. Dmand AI also links Dr. Amin to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amin practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Amin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Amin is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Amin's licenses on file in 3 states: Florida, Colorado and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Amin treats.

CMS data shows 62,357 Medicare services from Dr. Amin across 27 procedure codes in 2024, for 455 Medicare patients. Medicare paid $1,185,806 for them.

CMS counts 455 Medicare patients who saw Dr. Amin in 2024. The largest group is 65 to 74, with 190 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amin's median patient age at 72, with 61% women.

In 2024, Dr. Amin wrote 3,184 Medicare Part D claims for 525 patients. 72% of them were for generic drugs. CMS names the drug for 2,811 of them, across 70 drugs with 11 or more claims each, at $8,422,419 in total drug cost. In 2023, CMS named 2,546 claims across 60 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Amin for performance year 2024, reported individually. Dr. Amin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Amin, published from 2010 to 2022. The most frequent topics are Myocardial Infarction, Cardiovascular Diseases and Electrocardiography. Dr. Amin has published most often in Arch Med Sci. Dr. Amin's most frequent co-author is Harit V. Desai, MD.

CMS Open Payments shows 2,727 general payments to Dr. Amin from 85 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 39% of the total. Eli Lilly and Company paid the most, $95,776.

Dr. Amin is in network with 15 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.